相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Suppressive effects of flavonoid fisetin on lipopolysaccharide-induced microglial activation and neurotoxicity
Long Tai Zheng et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2008)
Complement C3 deficiency leads to accelerated amyloid β plaque deposition and neurodegeneration and modulation of the microglia/macrophage phenotype in amyloid precursor protein transgenic mice
Marcel Maier et al.
JOURNAL OF NEUROSCIENCE (2008)
Long-term effects of Aβ42 immunisation in Alzheimer's disease:: follow-up of a randomised, placebo-controlled phase I trial
Clive Holmes et al.
LANCET (2008)
Role of complement anaphylatoxin receptors (C3aR, C5aR) in the development of the rat cerebellum
Magalie Benard et al.
MOLECULAR IMMUNOLOGY (2008)
Epigallocatechin-3-O-gallate inhibits TNFα-induced monocyte chemotactic protein-1 production from vascular endothelial cells
Hee Yul Ahn et al.
LIFE SCIENCES (2008)
Analysis of cerebrospinal fluid of Alzheimer patients
Josef Marksteiner et al.
PHARMACOLOGY (2008)
The role of amyloid β peptide 42 in Alzheimer's disease
Mark A. Findeis
PHARMACOLOGY & THERAPEUTICS (2007)
Immunosuppressive effect of silibinin in experimental autoimmune encephalomyelitis
Kyungwon Min et al.
ARCHIVES OF PHARMACAL RESEARCH (2007)
Upregulation of amyloid precursor protein by platelet-derived growth factor in hippocampal precursor cells
Jung Su Lim et al.
NEUROREPORT (2007)
Systemic inflammation, infection, apoE alleles, and Alzheimer disease: A position paper
Caleb E. Finch et al.
CURRENT ALZHEIMER RESEARCH (2007)
Role of complement in neurodegeneration and neuroinflammation
Domenico Marco Bonifati et al.
MOLECULAR IMMUNOLOGY (2007)
A brief history of TH17, the first major revision in the TH1/TH2 hypothesis of T cell-mediated tissue damage
Lawrence Steinman
NATURE MEDICINE (2007)
Epigallocatechin-3-gallate enhances CD8+ T cell-mediated antitumor immunity induced by DNA vaccination
Tae Heung Kang et al.
CANCER RESEARCH (2007)
Complement proteins C1q and MBL are pattern recognition molecules that signal immediate and long-term protective immune functions
Suzanne S. Bohlson et al.
MOLECULAR IMMUNOLOGY (2007)
Inflammatory processes in Alzheimer's disease
Michael T. Heneka et al.
JOURNAL OF NEUROIMMUNOLOGY (2007)
Tea polyphenol inhibits allostimulation in mixed lymphocyte culture
Jong-Yoon Kim et al.
CELL TRANSPLANTATION (2007)
Neuroprotective effects of (-)-epigallocatechin-3-gallate in a transgenic mouse model of amyotrophic lateral sclerosis
Zhihao Xu et al.
NEUROCHEMICAL RESEARCH (2006)
LEF-1 is crucial for neutrophil granulocytopoiesis and its expression is severely reduced in congenital neutropenia
Julia Skokowa et al.
NATURE MEDICINE (2006)
Interleukin-1-induced neurotoxicity is mediated by glia and requires caspase activation and free radical release
Peter Thornton et al.
JOURNAL OF NEUROCHEMISTRY (2006)
ADAM10 activation is required for green tea (-)-epigallocatechin-3-gallate-induced α-secretase cleavage of amyloid precursor protein
Demian F. Obregon et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Transforming growth factor β2 autocrinally mediates neuronal cell death induced by amyloid-β
Y Hashimoto et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2006)
The role of complement in danger sensing and transmission
J Kohl
IMMUNOLOGIC RESEARCH (2006)
An estimate of the worldwide prevalence and direct costs of dementia in 2003
A Wimo et al.
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS (2006)
Measurement of thirteen biological markers in CSF of patients with Alzheimer's disease and other dementias
I Blasko et al.
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS (2006)
The cholinergic anti-inflammatory pathway
VA Pavlov et al.
BRAIN BEHAVIOR AND IMMUNITY (2005)
Cytokine production by a human microglial cell line:: Effects of β-amyloid and α-melanocyte-stimulating hormone
C Lindberg et al.
NEUROTOXICITY RESEARCH (2005)
Transforming growth factor β2 is a neuronal death-inducing ligand for amyloid-β precursor protein
Y Hashimoto et al.
MOLECULAR AND CELLULAR BIOLOGY (2005)
The flavonoid luteolin prevents lipopolysaccharide-induced NF-κB signalling and gene expression by blocking IκB kinase activity in intestinal epithelial cells and bone-marrow derived dendritic cells
JS Kim et al.
IMMUNOLOGY (2005)
Cytokine and chemokine inter-regulation in the inflamed or injured CNS
T Owens et al.
BRAIN RESEARCH REVIEWS (2005)
Glia and their cytokines in progression of neurodegeneration
RE Mrak et al.
NEUROBIOLOGY OF AGING (2005)
The role of inflammation in Alzheimer's disease
EE Tuppo et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2005)
The microglial activation continuum: from innate to adaptive responses
Terrence Town et al.
JOURNAL OF NEUROINFLAMMATION (2005)
IL-8 enhancement of amyloid-beta (Aβ1-42)-induced expression and production of pro-inflammatory cytokines and COX-2 in cultured human microglia
S Franciosi et al.
JOURNAL OF NEUROIMMUNOLOGY (2005)
Protective effects of insulin-like growth factor-I on the somatostatinergic system in the temporal cortex of β-amyloid-treated rats
D Aguado-Llera et al.
JOURNAL OF NEUROCHEMISTRY (2005)
Nasal vaccination with a proteosome-based adjuvant and glatiramer acetate clears beta-amyloid in a mouse model of Alzheimer disease
D Frenkel et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Alzheimer's disease beta-secretase BACE1 is not a neuron-specific enzyme
S Rossner et al.
JOURNAL OF NEUROCHEMISTRY (2005)
The microglial phagocytic role with specific plaque types in the Alzheimer disease brain
MR D'Andrea et al.
NEUROBIOLOGY OF AGING (2004)
Fe65 is not involved in the platelet-derived growth factor-induced processing of Alzheimer's amyloid precursor protein, which activates its caspase-directed cleavage
N Zambrano et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Blueberry supplemented diet: Effects on object recognition memory and nuclear factor-kappa B levels in aged rats
F Goyarzu et al.
NUTRITIONAL NEUROSCIENCE (2004)
Neuroinflammatory perspectives on the two faces of Alzheimer's disease
P Eikelenboom et al.
JOURNAL OF NEURAL TRANSMISSION (2004)
Rofecoxib - No effect on Alzheimer's disease in a 1-year, randomized, blinded, controlled study
SA Reines et al.
NEUROLOGY (2004)
Cytokines in neuroinflammation and Alzheimer's disease
M Cacquevel et al.
CURRENT DRUG TARGETS (2004)
Complement: a unique innate immune sensor for danger signals
P Gasque
MOLECULAR IMMUNOLOGY (2004)
Immunotherapy for Alzheimer's disease
DS Gelinas et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Midlife dietary intake of antioxidants and risk of late-life incident dementia - The Honolulu-Asia Aging Study
D Laurin et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2004)
Neurones treated with cyclo-oxygenase-1 inhibitors are resistant to amyloid-β1-42
C Bate et al.
NEUROREPORT (2003)
Amyloid-β:: a chameleon walking in two worlds:: a review of the trophic and toxic properties of amyloid-β
CS Atwood et al.
BRAIN RESEARCH REVIEWS (2003)
Yin and Yang: complement activation and regulation in Alzheimer's disease
Y Shen et al.
PROGRESS IN NEUROBIOLOGY (2003)
Non-steroidal anti-inflammatory drugs and cyclooxygenase in Alzheimer's disease
JJM Hoozemans et al.
CURRENT DRUG TARGETS (2003)
Alzheimer disease in the US population - Prevalence estimates using the 2000 census
LE Hebert et al.
ARCHIVES OF NEUROLOGY (2003)
NSAIDs and enantiomers of flurbiprofen target γ-secretase and lower Aβ42 in vivo
JL Eriksen et al.
JOURNAL OF CLINICAL INVESTIGATION (2003)
Effect of non-steroidal anti-inflammatory drugs on risk of Alzheimer's disease: systematic review and meta-analysis of observational studies
M Etminan et al.
BMJ-BRITISH MEDICAL JOURNAL (2003)
Effects of rofecoxib or naproxen vs placebo on Alzheimer disease progression - A randomized controlled trial
PS Aisen et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)
Inflammatory neurodegeneration mediated by nitric oxide, glutamate, and mitochondria
GC Brown et al.
MOLECULAR NEUROBIOLOGY (2003)
Blueberry supplementation enhances signaling and prevents behavioral deficits in an Alzheimer disease model
JA Joseph et al.
NUTRITIONAL NEUROSCIENCE (2003)
What can rodent models tell us about cognitive decline in Alzheimer's disease?
S Davis et al.
MOLECULAR NEUROBIOLOGY (2003)
Mechanisms of disease: Apoptosis and caspases in neurodegenerative diseases
RM Friedlander
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Genomic medicine: Alzheimer's disease and Parkinson's disease
RL Nussbaum et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Platelet-derived growth factor induces the β-γ-secretase-mediated cleavage of Alzheimer's amyloid precursor protein through a Src-Rac-dependent pathway
D Gianni et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Evaluation of the anti-oxidative effect (in vitro) of tea polyphenols
F Hashimoto et al.
BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY (2003)
Role of microglia in inflammation-mediated neurodegenerative diseases: Mechanisms and strategies for therapeutic intervention
B Liu et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2003)
IL-10 and glucocorticoids inhibit A beta(1-42) and lipopolysaccharide-induced pro-inflammatory cytokine and chemokine induction in the central nervous system
Ann Marie Szczepanik et al.
JOURNAL OF ALZHEIMERS DISEASE (2003)
Serum insulin-like growth factor I regulates brain amyloid-levels
E Carro et al.
NATURE MEDICINE (2002)
The possible role of complement activation in Alzheimer disease
PL McGeer et al.
TRENDS IN MOLECULAR MEDICINE (2002)
Expression and regulation of interleukin-10 and interleukin-10 receptor in rat astroglial and microglial cells
A Ledeboer et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2002)
A microdialysis method for the recovery of IL-1β, IL-6 and nerve growth factor from human brain in vivo
CD Winter et al.
JOURNAL OF NEUROSCIENCE METHODS (2002)
The potential of anti-inflammatory drugs for the treatment of Alzheimer's disease
PS Aisen
LANCET NEUROLOGY (2002)
Prominent neurodegeneration and increased plaque formation in complement-inhibited Alzheimer's mice
T Wyss-Coray et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Distinct functions of COX-1 and COX-2
I Morita
PROSTAGLANDINS & OTHER LIPID MEDIATORS (2002)
Dietary intake of antioxidants and risk of Alzheimer disease
MJ Engelhart et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2002)
Amyloid precursor protein gene disruption attenuates degeneration of substantia nigra compacta neurons following axotomy
LA DeGiorgio et al.
BRAIN RESEARCH (2002)
Up-regulation of the inflammatory cytokines IFN-γ and IL-12 and down-regulation of IL-4 in cerebral cortex regions of APPSWE transgenic mice
N Abbas et al.
JOURNAL OF NEUROIMMUNOLOGY (2002)
Peroxisome proliferator-activated receptor-gamma agonists inhibit experimental allergic encephalomyelitis by blocking IL-12 production, IL-12 signaling and Th1 differentiation
C Natarajan et al.
GENES AND IMMUNITY (2002)
Loss of basal Forebrain p75NTR immunoreactivity in subjects with mild cognitive impairment and Alzheimer's disease
EJ Mufson et al.
JOURNAL OF COMPARATIVE NEUROLOGY (2002)
Pathways of inflammatory activation in Alzheimer's disease: Potential targets for disease modifying drugs
M Hull et al.
CURRENT MEDICINAL CHEMISTRY (2002)
Increased intrathecal levels of the angiogenic factors VEGF and TGF-beta in Alzheimer's disease and vascular dementia
E Tarkowski et al.
NEUROBIOLOGY OF AGING (2002)
Ibuprofen decreases cytokine-induced amyloid beta production in neuronal cells
I Blasko et al.
NEUROBIOLOGY OF DISEASE (2001)
Nonsteroidal antiinflammatory drugs and the risk of Alzheimer's disease
BA in 't Veld et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
A subset of NSAIDs lower amyloidogenic Aβ42 independently of cyclooxygenase activity
S Weggen et al.
NATURE (2001)
Do NSAIDs prevent Alzheimer's disease? And, if so, why? The epidemiological evidence
PP Zandi et al.
NEUROBIOLOGY OF AGING (2001)
Complement in Alzheimer's disease: opportunities for modulating protective and pathogenic events
AJ Tenner
NEUROBIOLOGY OF AGING (2001)
The role of TNF and its receptors in Alzheimer's disease
RT Perry et al.
NEUROBIOLOGY OF AGING (2001)
Interleukin-1, neuroinflammation, and Alzheimer's disease
RE Mrak et al.
NEUROBIOLOGY OF AGING (2001)
Postmortem studies of the effect of anti-inflammatory drugs on Alzheimer-type pathology and associated inflammation
IRA Mackenzie
NEUROBIOLOGY OF AGING (2001)
Anti-inflammatory actions of peroxisome proliferator-activated receptor gamma agonists in Alzheimer's disease
GE Landreth et al.
NEUROBIOLOGY OF AGING (2001)
Estrogen (E2) and glucocorticoid (Gc) effects on microglia and Aβ clearance in vitro and in vivo
ME Harris-White et al.
NEUROCHEMISTRY INTERNATIONAL (2001)
Regulation of β-amyloid stimulated proinflammatory responses by peroxisome proliferator-activated receptor α
CK Combs et al.
NEUROCHEMISTRY INTERNATIONAL (2001)
Neuronal and glial coexpression of argininosuccinate synthetase and inducible nitric oxide synthase in Alzheimer disease
MT Heneka et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2001)
The precursor pro-nerve growth factor is the predominant form of nerve growth factor in brain and is increased in Alzheimer's disease
M Fahnestock et al.
MOLECULAR AND CELLULAR NEUROSCIENCE (2001)
CXCR4-activated astrocyte glutamate release via TNFa: amplification by microglia triggers neurotoxicity
P Bezzi et al.
NATURE NEUROSCIENCE (2001)
Increased CSF cortisol in AD is a function of APOE genotype
ER Peskind et al.
NEUROLOGY (2001)
Neuronal expression of a functional receptor for the C5a complement activation fragment
SA O'Barr et al.
JOURNAL OF IMMUNOLOGY (2001)
IL-4, IL-10 and IL-13 modulate Aβ(1-42)-induced cytokine and chemokine production in primary murine microglia and a human monocyte cell line
AM Szczepanik et al.
JOURNAL OF NEUROIMMUNOLOGY (2001)
Pineal and pituitary-adrenocortical function in physiological aging and in senile dementia
E Ferrari et al.
EXPERIMENTAL GERONTOLOGY (2000)
Cyclooxygenases in the central nervous system: Implications for treatment of neurological disorders
A Yermakova et al.
CURRENT PHARMACEUTICAL DESIGN (2000)
The role of complement in Alzheimer's disease pathology
MR Emmerling et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2000)
The role of complement anaphylatoxin C5a in neurodegeneration: implications in Alzheimer's disease
P Mukherjee et al.
JOURNAL OF NEUROIMMUNOLOGY (2000)
Oxidative stress induces intracellular accumulation of amyloid β-protein (Aβ) in human neuroblastoma cells
H Misonou et al.
BIOCHEMISTRY (2000)
Increased CSF levels of nerve growth factor in patients with Alzheimer's disease
C Hock et al.
NEUROLOGY (2000)
Brain aging and midlife tofu consumption
LR White et al.
JOURNAL OF THE AMERICAN COLLEGE OF NUTRITION (2000)
Inflammation and Alzheimer's disease
H Akiyama et al.
NEUROBIOLOGY OF AGING (2000)
A randomized controlled trial of prednisone in Alzheimer's disease
PS Aisen et al.
NEUROLOGY (2000)
Intake of flavonoids and risk of dementia
D Commenges et al.
EUROPEAN JOURNAL OF EPIDEMIOLOGY (2000)
Alzheimer's disease and inflammation: A review of cellular and therapeutic mechanisms
G Halliday et al.
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2000)
分享论文
